Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Use of Preemptive Pharmacogenomic Testing to Personalize Supportive Oncology

NCT04500301 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT04500301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Use of Preemptive Pharmacogenomic Testing to Personalize Supportive Oncology
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
December 2, 2020
Completion date
December 13, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, depression, pain